The bill enacts new sections 3727.81, 3727.811, and 5119.192 of the Revised Code, which mandate that hospitals provide overdose reversal drugs to patients under specific circumstances. According to section 3727.81, hospitals must offer an overdose reversal drug to patients discharged from the emergency department if they exhibited symptoms of an opioid overdose or related issues. However, there are exceptions where hospitals are not required to provide the drug, such as if the treating practitioner deems it inappropriate, the patient already possesses the drug, the hospital lacks a supply, or the patient refuses it. Additionally, hospitals must provide information on the drug's use and related services.

Section 3727.811 requires hospitals to document instances of overdose reversal drug provision and submit reports to the departments of health and behavioral health, ensuring patient anonymity. Section 5119.192 outlines that the department of behavioral health will supply hospitals with overdose reversal drugs, contingent on available funding, and will establish reporting standards in collaboration with the department of health. The bill also includes provisions to protect hospitals and their staff from liability when fulfilling these requirements.